Quantcast

Latest Pharmaceutical drug Stories

2014-01-14 23:02:31

The Firm is investigating Lipitor lawsuits on behalf of patients who developed Type 2 diabetes, allegedly due to Lipitor. New York, NY (PRWEB) January 14, 2014 As dozens of Lipitor lawsuits (http://www.thelipitorlawsuit.com/ ) alleging use of the statin caused patients to develop Type 2 diabetes continue to move forward in courts around the country, Bernstein Liebhard LLP notes that Pfizer Inc. has also been named a defendant in a new whistleblower lawsuit involving the...

2014-01-10 23:19:58

ResearchMoz.us include new market research report "Research Report on China Antidiabetic Drug Market, 2014-2018" to its huge collection of research reports. Full Report With TOC @ http://www.researchmoz.us/research-report-on-china-antidiabetic-drug-market-2014-2018-report.html. Albany, NewYork (PRWEB) January 10, 2014 In 2013, the diabetes prevalence rate of grown-ups aged in 20 to 79 was 8.3% in the globe. The number of sufferers reached 382 million. 80% of the patients lives...

FDA Approves Novel AstraZeneca, Bristol-Meyers Squibb Diabetes Drug
2014-01-10 11:37:58

Ranjini Raghunath for redOrbit.com - Your Universe Online The FDA has approved the use of a new Type 2 diabetes drug called Farxiga, developed by pharmaceutical companies Bristol-Meyers Squibb and AstraZeneca. Type 2 diabetes affects 24 million people in the US and nearly 350 million people worldwide. Conventional diabetes drugs work by reducing the amount of sugar the body absorbs from food or by boosting the production of insulin which disposes of excess sugar. Farxiga, however,...

2014-01-08 20:21:24

Ask Agency to require that biosimilars bear distinguishable names to enhance patient safety WASHINGTON, Jan. 8, 2014 /PRNewswire-USNewswire/ -- The Janssen Pharmaceutical Companies of Johnson & Johnson (Janssen) today submitted a Citizen Petition to the U.S. Food and Drug Administration (FDA) asking the agency to require biosimilars to bear nonproprietary names that are similar to, but not the same as, those of their reference products or of other biosimilars. The Petition states...

2014-01-08 16:25:55

PITTSBURGH, Jan. 8, 2014 /PRNewswire/ -- Mylan Inc. (Nasdaq: MYL) today announced the appointment of Adele Gulfo as executive vice president, Global Collaboration and Strategic Operations. Gulfo will serve as a member of Mylan's executive leadership team. Prior to joining Mylan, Gulfo served as regional president of Latin America in Pfizer's Emerging Markets Business Unit. In this capacity, she led a team of over 4,000 colleagues operating across more than 23 countries. In 2012,...

2014-01-06 08:26:38

SAO PAULO, Jan. 6, 2014 /PRNewswire/ -- moksha8, a leader in the commercialization of CNS medicines in Latin America, today announced that it has filed applications with the Brazilian regulatory authority, ANVISA, for approval of Viibryd® (vilazodone) for major depressive disorders and Colobreathe (colistimethate sodium) to treat lung infections in patients with cystic fibrosis. moksha8 and Forest Laboratories have also amended the strategic alliance they signed in 2012. Forest...

2013-12-20 13:32:03

The 2009 costs of antibiotics covered by private insurance companies in the U.S. for children younger than 10 years old were estimated to be more than five times higher than the costs in the United Kingdom (U.K.), which are covered by a government universal health plan. These results, from Boston University's Boston Collaborative Drug Surveillance Program, are a follow up of an ongoing comparison of prescription drug costs between the U.S. and U.K. The initial results reported on relative...

2013-12-18 23:28:52

The Long Island law firm of Rudolph F. X. Migliore has announced that the firm is investigating claims of post-menopausal women who developed new on-set Type 2 diabetes after taking the popular statin drug, Lipitor. Commack, New York (PRWEB) December 18, 2013 The Commack, NY law firm Rudolph F. X. Migliore, P.C. has announced the firm is now accepting cases on behalf of post-menopausal women who have taken the prescription drug Lipitor and later developed new on-set Type 2 diabetes....

2013-12-18 23:27:54

As illicit use of opioids for pain management continues to be an issue in healthcare, leading long-term care pharmacy PharmScript offers tips on how nurses can to detect and report the misuse of pain medications for non-therapeutic purposes. Edison, NJ (PRWEB) December 18, 2013 As illicit use of opioids for pain management continues to be an issue in healthcare, leading long-term care pharmacy PharmScript offers tips on how nurses can to detect and report the misuse of pain medications...

GSK Stops Paying Docs To Market Meds
2013-12-18 09:15:55

Rebekah Eliason for redOrbit.com – Your Universe Online Amid accusations of bribery and scandal, GlaxoSmithKline (GSK), one of the leading drug makers, will stop paying doctors to promote its drugs and cease targets for number of prescriptions filled for the marketing staff. This is a first for the giant drug company, which has long been fighting scandals over its sales practices. Such a huge step is a major challenge to other drug companies and could force them to follow their example....


Word of the Day
monteith
  • A large punch-bowl of the eighteenth century, usually of silver and with a movable rim, and decorated with flutings and a scalloped edge. It was also used for cooling and carrying wine-glasses.
  • A kind of cotton handkerchief having white spots on a colored ground, the spots being produced by a chemical which discharges the color.
This word is possibly named after Monteith (Monteigh), 'an eccentric 17th-century Scotsman who wore a cloak scalloped at the hem.'
Related